Study Finds Diabetes Medication Reduces Risk Of Death And Heart Disease In People With Arthritis August 12, 2024 (Vancouver) A study conducted by Arthritis Research Canada has revealed that certain diabetes medications, specifically glucagon-like peptide-1 receptor agonists (GLP-1-RAs) like semaglutide (Ozempic), reduced the risk of death and heart attacks in people with immune-mediated inflammatory diseases (IMIDs), such as rheumatoid arthritis, psoriasis, and lupus, who also have type 2 diabetes
We take the time to evaluate each patient as an individual, and can help select which treatment modality is most appropriate for your specific pain needs
Which States Cover Wegovy Under Medicaid in 2026
These may include pancreatitis, gallbladder issues, dehydration-related kidney problems, or severe gastrointestinal symptoms
Obesity reviews, 17(10), 970-976
Gout is a type of inflammatory arthritis that, according to the National Kidney Foundation, affects 8.3 million adults (6.1 million men, 2.2 million women), 3.9 percent of which are U.S
